Likuiditas cepet Advanced Biomed Inc (ADVB)

This daily price action for Advanced Biomed Inc (ADVB) on the GURU.Markets platform reflects the asset's dynamics, with a value of 9.70. Advanced Biomed Inc implements computer modeling and robotics to optimize cancer cell analysis. Business growth is driven by the launch of blood analysis diagnostic systems and expansion into the US. The project is currently in the development stage, with funding provided by investor contributions.

The stability of Advanced Biomed Inc (ADVB) depends directly on the successful market launch of diagnostic systems, which requires strict liquidity control to cover regulatory costs. This ratio excludes illiquid inventories, assessing the company's ability to settle short-term debts using only cash and accounts receivable. A decline in the agility of covering current liabilities signals an increasing risk of default and the issuer's financial vulnerability.